General Information of Drug Transporter (DT)
DT ID DTD0205 Transporter Info
Gene Name SLC25A42
Transporter Name Mitochondrial coenzyme A transporter SLC25A42
Gene ID
284439
UniProt ID
Q86VD7
Post-Translational Modification of This DT
Overview of SLC25A42 Modification Sites with Functional and Structural Information
Sequence
PTM type
X-Methylation X-Phosphorylation X: Amino Acid

Methylation

  Arginine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC25A42 [1]

Role of PTM

Potential impacts

Modified Residue

Arginine

Modified Location

56

Experimental Method

Co-Immunoprecipitation

Detailed Description

Methylation at SLC25A42 Arginine 56 has the potential to affect its expression or activity.

Phosphorylation

  Serine

          9 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC25A42 [2] , [3]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

21

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC25A42 Serine 21 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC25A42 [4] , [5]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

23

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC25A42 Serine 23 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence SLC25A42 [2] , [4]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

25

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC25A42 Serine 25 has the potential to affect its expression or activity.

  PTM Phenomenon 4

Have the potential to influence SLC25A42 [2] , [4]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

26

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC25A42 Serine 26 has the potential to affect its expression or activity.

  PTM Phenomenon 5

Have the potential to influence SLC25A42 [4] , [5]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

35

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC25A42 Serine 35 has the potential to affect its expression or activity.

  PTM Phenomenon 6

Have the potential to influence SLC25A42 [4] , [5]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

36

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC25A42 Serine 36 has the potential to affect its expression or activity.

  PTM Phenomenon 7

Have the potential to influence SLC25A42 [6]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

88

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC25A42 Serine 88 has the potential to affect its expression or activity.

  PTM Phenomenon 8

Have the potential to influence SLC25A42 [7]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

168

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC25A42 Serine 168 has the potential to affect its expression or activity.

  PTM Phenomenon 9

Have the potential to influence SLC25A42 [8]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

266

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC25A42 Serine 266 has the potential to affect its expression or activity.

  Threonine

          5 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC25A42 [9]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

96

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC25A42 Threonine 96 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC25A42 [10]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

149

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC25A42 Threonine 149 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence SLC25A42 [8]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

256

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC25A42 Threonine 256 has the potential to affect its expression or activity.

  PTM Phenomenon 4

Have the potential to influence SLC25A42 [8]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

270

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC25A42 Threonine 270 has the potential to affect its expression or activity.

  PTM Phenomenon 5

Have the potential to influence SLC25A42 [8]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

273

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC25A42 Threonine 273 has the potential to affect its expression or activity.

  Tyrosine

          2 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC25A42 [7]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

167

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC25A42 Tyrosine 167 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC25A42 [11]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

262

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC25A42 Tyrosine 262 has the potential to affect its expression or activity.
References
1 Factors affecting emotional instability in female rheumatoid arthritis outpatients with limited functional disorder. Mod Rheumatol. 2000 Dec;10(4):240-6.
2 Global phosphoproteomic analysis reveals ARMC10 as an AMPK substrate that regulates mitochondrial dynamics. Nat Commun. 2019 Jan 10;10(1):104.
3 Improve the coverage for the analysis of phosphoproteome of HeLa cells by a tandem digestion approach. J Proteome Res. 2012 May 4;11(5):2828-37.
4 Systematic functional prioritization of protein posttranslational modifications. Cell. 2012 Jul 20;150(2):413-25.
5 Automated phosphoproteome analysis for cultured cancer cells by two-dimensional nanoLC-MS using a calcined titania/C18 biphasic column. Anal Sci. 2008 Jan;24(1):161-6.
6 Ischemia in tumors induces early and sustained phosphorylation changes in stress kinase pathways but does not affect global protein levels. Mol Cell Proteomics. 2014 Jul;13(7):1690-704.
7 HIV-1 Activates T Cell Signaling Independently of Antigen to Drive Viral Spread. Cell Rep. 2017 Jan 24;18(4):1062-1074.
8 iTRAQ labeling is superior to mTRAQ for quantitative global proteomics and phosphoproteomics. Mol Cell Proteomics. 2012 Jun;11(6):M111.014423.
9 Identification of Missing Proteins in the Phosphoproteome of Kidney Cancer. J Proteome Res. 2017 Dec 1;16(12):4364-4373.
10 Non-alcoholic fatty liver disease phosphoproteomics: A functional piece of the precision puzzle. Hepatol Res. 2017 Dec;47(13):1469-1483.
11 Neuroblastoma tyrosine kinase signaling networks involve FYN and LYN in endosomes and lipid rafts. PLoS Comput Biol. 2015 Apr 17;11(4):e1004130.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.